RJA
DVAX

Raymond James & Associates’s Dynavax Technologies DVAX Stock Holding History

Raymond James & Associates’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$113K Buy
+10,125
New +$112K ﹤0.01% 3770
2022
Q1 		– Sell
-10,848
Closed -$153K – 4156
2021
Q4 		$153K Buy
+10,848
New +$178K ﹤0.01% 3773
2021
Q1 		– Sell
-51,848
Closed -$231K – 4021
2020
Q4 		$231K Buy
51,848
+8,540
+20% +$38.7K ﹤0.01% 3286
2020
Q3 		$187K Sell
43,308
-16,400
-27% -$117K ﹤0.01% 3241
2020
Q2 		$530K Buy
+59,708
New +$302K ﹤0.01% 2542
2019
Q3 		– Sell
-25,177
Closed -$100K – 3633
2019
Q2 		$100K Sell
25,177
-6,626
-21% -$38.4K ﹤0.01% 3408
2019
Q1 		$232K Buy
31,803
+2,921
+10% +$28.6K ﹤0.01% 3140
2018
Q4 		$264K Sell
28,882
-4,680
-14% -$51.8K ﹤0.01% 2949
2018
Q3 		$416K Sell
33,562
-873
-3% -$11.8K ﹤0.01% 2832
2018
Q2 		$525K Buy
+34,435
New +$595K ﹤0.01% 2648
2017
Q4 		– Sell
-11,673
Closed -$251K – 3452
2017
Q3 		$251K Buy
+11,673
New +$185K ﹤0.01% 2901
2017
Q1 		– Sell
-10,482
Closed -$41K – 3316
2016
Q4 		$41K Sell
10,482
-330
-3% -$2.42K ﹤0.01% 3103
2016
Q3 		$113K Buy
+10,812
New +$155K ﹤0.01% 2978
2015
Q4 		– Sell
-24,380
Closed -$598K – 2343
2015
Q3 		$598K Buy
24,380
+943
+4% +$26.7K ﹤0.01% 1848
2015
Q2 		$549K Sell
23,437
-1,380
-6% -$30.1K ﹤0.01% 2048
2015
Q1 		$557K Buy
+24,817
New +$476K ﹤0.01% 1990

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James & Associates's DVAX Position: Q3 2024 in Review

Raymond James & Associates opened a new position in Dynavax Technologies (DVAX) in Q3 2024: 10,125 shares worth $113K. The stake represents ﹤0.01% of the portfolio and ranks #3770 among its holdings. This is a return to the name: Raymond James & Associates previously reported a position in DVAX as recently as Q4 2021.

Raymond James & Associates first reported a position in DVAX in Q1 2015 and has held it in 16 quarters since. The position peaked at $598K in Q3 2015. 251 funds tracked by Wall St. Rank hold DVAX as of Q3 2024.

  • Raymond James & Associates held 10,125 shares of Dynavax Technologies worth $113K as of Q3 2024.
  • Dynavax Technologies was a new Raymond James & Associates position in Q3 2024.
  • Dynavax Technologies made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3770 holding.
  • Raymond James & Associates first reported a position in Dynavax Technologies in Q1 2015 and has held it in 16 quarters since.
  • Raymond James & Associates's Dynavax Technologies position peaked at $598K in Q3 2015.
  • 251 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.